Search research articles
Contact Us
Filters
Showing results (201-210 of 684) with videos related to
Page
of 69
Sort By:
Journal of the Neurological Sciences
|
July 19, 2011
Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia
Cynthia L Comella, Joseph Jankovic, Daniel D Truong, et al.
Neuromuscular Disorders : NMD
|
May 1, 1996
Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle
P Juzans, J X Comella, J Molgo, et al.
Oncology
|
July 16, 2005
Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients
Giuseppe Frasci, Giuseppe D'Aiuto, Renato Thomas, et al.
Neurology
|
October 24, 2001
Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome
K Kompoliti, C G Goetz, S Leurgans, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 22, 2011
Pre-operative evaluations for DBS in dystonia
Stéphane Thobois, Takaomi Taira, Cynthia Comella, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
March 1, 1993
Effects of stonefish (Synanceia trachynis) venom on murine and frog neuromuscular junctions
A S Kreger, J Molgó, J X Comella, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
September 11, 2017
Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?
H A Jinnah, Cynthia L Comella, Joel Perlmutter, et al.
Molecular and Cellular Neurosciences
|
March 23, 2004
Differential involvement of phosphatidylinositol 3-kinase and p42/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic effects on cultured striatal neurons
Núria Gavaldà, Esther Pérez-Navarro, Elena Gratacòs, et al.
Neurology
|
March 1, 1994
Physical therapy and Parkinson's disease: a controlled clinical trial
C L Comella, G T Stebbins, N Brown-Toms, et al.
Biotechnology and Bioengineering
|
December 18, 2001
Mobility measurements of immunomagnetically labeled cells allow quantitation of secondary antibody binding amplification
K E McCloskey, K Comella, J J Chalmers, et al.
Page
of 69
Search research articles
Search
Showing results (201-210 of 684) with videos related to
Sort By:
Page
of 69
Journal of the Neurological Sciences
|
July 19, 2011
Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia
Cynthia L Comella, Joseph Jankovic, Daniel D Truong, et al.
Neuromuscular Disorders : NMD
|
May 1, 1996
Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle
P Juzans, J X Comella, J Molgo, et al.
Oncology
|
July 16, 2005
Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients
Giuseppe Frasci, Giuseppe D'Aiuto, Renato Thomas, et al.
Neurology
|
October 24, 2001
Estrogen, progesterone, and tic severity in women with Gilles de la Tourette syndrome
K Kompoliti, C G Goetz, S Leurgans, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 22, 2011
Pre-operative evaluations for DBS in dystonia
Stéphane Thobois, Takaomi Taira, Cynthia Comella, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
March 1, 1993
Effects of stonefish (Synanceia trachynis) venom on murine and frog neuromuscular junctions
A S Kreger, J Molgó, J X Comella, et al.
Toxicon : Official Journal of the International Society on Toxinology
|
September 11, 2017
Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?
H A Jinnah, Cynthia L Comella, Joel Perlmutter, et al.
Molecular and Cellular Neurosciences
|
March 23, 2004
Differential involvement of phosphatidylinositol 3-kinase and p42/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic effects on cultured striatal neurons
Núria Gavaldà, Esther Pérez-Navarro, Elena Gratacòs, et al.
Neurology
|
March 1, 1994
Physical therapy and Parkinson's disease: a controlled clinical trial
C L Comella, G T Stebbins, N Brown-Toms, et al.
Biotechnology and Bioengineering
|
December 18, 2001
Mobility measurements of immunomagnetically labeled cells allow quantitation of secondary antibody binding amplification
K E McCloskey, K Comella, J J Chalmers, et al.
Page
of 69